SynAbs inks agreement with SKLM as new distributor for its unique catalogue of monoclonal antibodies in Morocco

SynAbs is proud to announce strategic deal with successful company SKLM. SKLM already distributes major references in the field of monoclonal antibodies and will consequently extends its catalogue with unique mAbs references from SynAbs. Under the terms of the agreement, SKLM will have access to unique portfolio of rats and guinea pigs mAbs to address Morocco territories needs in R&D and IVD fields.